Ozempic and PCOS: Can It Help with Symptoms
doi: 10.1017/S0031182099004564 24 JemaM.FezaiM.BissingerR.LangF
Potential for misuse and addiction : Ozempic isn't a controlled substance, but misuse concerns exist
Rapid weight loss , a desired therapeutic effect of GLP-1 therapy, may theoretically contribute
According to NICE guidance (NG28), the continuation of GLP-1 receptor agonist therapy in type 2 diabetes should be assessed after six months, with treatment continued only if there is a reduction in HbA1c of at least 11 mmol/mol (1%) and, where applicable, a weight loss of at least 3% of initial body weight
Psychological support is, therefore, an integral component of comprehensive DPN management